Sustainability
With innovative technologies, Sartorius helps to accelerate progress in biopharmaceutical research and production so that more people have access to new medicines, therapies, and vaccines. This is how our business contributes to better medical care for people around the world and thus to social sustainability.
Reporting
Here you can find our Non-Financial Statement for 2023, in which we report on our progress towards achieving more sustainability.
- Non-financial Group Statement 2023 PDF | 689.8 KB
Here you can find our Sustainability Report for 2023 according to GRI, Global Compact, TCFD and SDG.
- Sartorius Sustainability Report 2023 PDF | 8.5 MB
Diversity is an important factor for us. Around 14,600 people from 113 nations work together for our success. Find out more about diversity at our company here.
- Insights into Diversity at Sartorius PDF | 812.9 KB
Ratings
Sartorius’ sustainability performance is regularly assessed by ESG rating agencies. The results are incorporated into our activities for continuous improvement.
In addition, Sartorius AG is listed in the DAX ESG 50 sustainability index of Deutsche Börse. The index lists the leading 50 companies based on ESG (Environmental, Social, Governance) performance, market capitalization and sales revenue.